SEC Form 4 · accession 0001624044-17-000002
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher L Gaenzle
Officer — CAO, GC & Sec
Period of report
Jan 19, 2017
Accepted (ET)
Jan 23, 2017 · 6:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jan 19, 2017 | F | 1,077 | $50.55 | D | 40,223 | D | |
| Class A Common StockF2 | Jan 20, 2017 | S | 1,186 | $50.089 | D | 39,037 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2016.
- F2The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $49.75 to $50.45, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.